Debio 0719 - Debiopharm

Home » Media » Publications

Debio 0719

Date	Article Title
23 Feb 2009	Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist
15 Aug 2008	Cross-talk between LPA1 and Epidermal Growth Factor Receptors Mediates Up-regulation of Sphingosine Kinase 1 to Promote Gastric Cancer Cell Motility and Invasion
20 Jun 2006	The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases
23 Apr 2004	Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and non-neoplastic cells through LPA
20 Feb 2004	Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA
16 Jul 2003	Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

Latest News

09 November 2011 Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease

05 October 2011 The Japanese Cancer Association and Debiopharm Group™ present Doctors Arakawa and Kurokawa with the 2011 ‘JCA-Mauvernay Award’for their innovative and outstanding research in the field of cancer

08 September 2011 Debiopharm Group™ presents the ‘Debiopharm Group™ Life Sciences Award 2011’ and two ‘Junior Debiopharm Group™ Awards 2011’ at the ISREC 2011 Life Sciences Symposium

Debiopharm on

© 2012 Debiopharm Group